Jump to any asset
849 assets, updated daily
As of September 27, 2026, Astera Labs, Inc. (ALAB) trades at $364.62. CleaRank Financial AI rates it Buy with a fair value of $425.00, 16.6% above the current price. Wall Street's consensus target is $425.00 across 26 analysts. RSI at 63 is in neutral territory, and the price is above its 50-day average of $305.03.
Astera Labs, Inc. (ALAB)
Astera Labs, Inc. NASDAQ
$364.62
4.110 (1.14%)
At close: Sep 25, 4:00 PM EDT
AI Analyst Consensus
75 / 100
Astera Labs, Inc. (ALAB) is currently trading at $364.62, above its 50-day and 200-day moving averages ($305.03 and $236.21), indicating positive short-to-medium term momentum. The company has demonstrated exceptional revenue growth, exceeding 100% year-over-year in recent quarters, and analysts project continued strong expansion. Its profit margins are healthy, and its balance sheet is strong with minimal debt. However, a significant headwind exists in the form of heavy insider selling, with over $1.2 billion in sales reported. While the company's fundamental performance and analyst ratings are largely positive, this insider activity suggests potential concerns or profit-taking that investors should monitor closely. The stock's valuation, while supported by growth, is also elevated compared to sector averages.
ALAB Price Analysis
Market Metrics
Open
$366.00
Day Range
$356.20 to $377.87
Prev Close
$360.51
Volume
3.07M
52-Week Range
$97.89 to $499.48
Market Cap
$63.26B
Peer Benchmarking
Valuation vs Sector (Technology)
Performance vs XLK
Sector Position Analysis
Trading at a significant premium to sector peers (+431%), suggesting market expectations for superior growth or market position.
ALAB Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 3 quarters, ALAB beat estimates 3 times. However, the stock fell 3 times the next day. This suggests positive news is often "priced in" or investors are selling the news.
ALAB Analysis
Company's Health
4/5
12-Month Analyst Target
+16.56% Upside
Median of 26 analysts (12-month)
$425.00
AI Technical Analysis
Astera Labs, Inc. is exhibiting bullish momentum, with its Relative Strength Index (RSI) at 62.75, indicating strength without being overbought. The stock is trading above its 50-day and 200-day moving averages ($305.03 and $236.21), and also above its 20-day exponential moving average ($316.35), signaling an uptrend. Volume has been below average recently, which could suggest a pause in the upward momentum. Key support levels are near the 50-day SMA, while resistance is less defined given the stock's recent performance. The MACD indicator at 13.64 also supports the bullish trend. Investors should watch for continued price action above these moving averages to confirm the trend's continuation.
ProTips
- Monitor insider selling closely; over $1.2 billion in sales warrants significant attention and could signal a peak or profit-taking.
- The stock is trading above key moving averages (50-day and 200-day SMA), indicating positive technical momentum, but watch for volume confirmation.
- Given the high valuation multiples, consider position sizing carefully and maintain a disciplined risk-management approach, potentially using stop-losses below key support levels.
Key Catalysts
Bullish
Strong Revenue Growth Projections
Analysts project revenue to reach $2.9 billion next year, a 56% increase, driven by strong demand for its semiconductor solutions.
Source: Wall Street Revenue EstimatesBullish
Positive Analyst Sentiment
The majority of analysts maintain Buy or Outperform ratings, with a median price target of $425.00, indicating confidence in future performance.
Source: Wall Street Analyst RatingsBearish
Heavy Insider Selling
Insiders have sold over $1.2 billion in stock, with no reported purchases, signaling potential concerns or profit-taking at current price levels.
Source: Insider SummaryBearish
Premium Valuation
The stock trades at significantly higher P/E and P/S ratios compared to sector averages, making it vulnerable to valuation corrections.
Source: Fundamental AnalysisMarket Outlook
Astera Labs, Inc. is projected to continue its strong growth trajectory, with analysts forecasting revenue to reach approximately $2.9 billion next year, representing a 56% increase year-over-year. The company's strong profitability and minimal debt provide a solid foundation for this expansion. The median analyst price target of $425.00 suggests a potential upside of 16.6% from the current price, reflecting confidence in its future performance. However, the outlook is tempered by significant insider selling and a high valuation. Any deceleration in its hyper-growth rate or a broader market downturn could lead to a sharp correction, especially given the premium at which the stock trades. Investors should closely watch upcoming earnings reports and insider transaction filings for shifts in sentiment.
Key Statistics
| Market Cap | 63.26B |
|---|---|
| P/E Ratio | 180.50 |
| EPS (TTM) | 2.02 |
| Dividend Yield | 0.00% |
| 52 Week High | 499.48 |
| 52 Week Low | 97.89 |
Astera Labs, Inc. trades at a high Price-to-Earnings (P/E) ratio of 180.50, significantly above the technology sector median of 34, reflecting its high growth expectations. Its Price-to-Sales (P/S) ratio of 52.63 is also substantially higher than the sector average of 7.5. Despite this premium valuation, the company boasts a strong return on equity of 25.83% and healthy profit margins of 30.74%. The company's balance sheet is exceptionally strong, with a debt-to-equity ratio of only 0.03, indicating minimal leverage. While the current valuation appears stretched when compared to sector averages, the company's rapid revenue growth (104.5% YoY) and profitability provide some justification. Investors must weigh the premium valuation against the company's impressive growth and financial health.
Earnings & Growth Analysis
Astera Labs, Inc. reported a strong earnings beat for the quarter ending June 2026, with actual EPS of $0.80 exceeding the estimate of $0.69 by 15.94%, though this was followed by an 11.96% price drop. Prior to this, the company had a mixed earnings history, with a significant EPS miss in the quarter ending June 2026 (actual -0.03 vs estimate 0.03) and a substantial price decline following the December 2025 quarter's earnings. Revenue growth remains exceptionally high, with the current quarter expected to see a 139.00% year-over-year increase.
Key Risks
The primary risk for Astera Labs, Inc. is the significant insider selling, totaling over $1.2 billion, which could signal a lack of confidence or a peak in valuation from management's perspective. The stock also trades at a substantial premium to sector averages on both P/E and P/S metrics, making it vulnerable to any slowdown in its hyper-growth trajectory or shifts in market sentiment towards high-valuation stocks. Also, the recent earnings report for June 2026, despite beating estimates, was met with a price decline, indicating that even positive results may not be enough to sustain upward momentum in the current environment.
Technical Indicators
| RSI (14) | 62.75 |
|---|---|
| MACD | 13.64 |
| SMA 50 | 305.03 |
| SMA 200 | 236.21 |
RSI
Bullish
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($305.03) above the 200-day SMA ($236.21), price action is firmly bullish above key moving averages.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.47
Moderate correlation
Nasdaq 100 (QQQ)
+0.57
Moderate correlation
Bitcoin (BTC)
+0.25
Weak correlation
Gold (XAU)
+0.08
Weak correlation
Check Custom Correlation
How does any other asset move with ALAB? One year of daily closes, Pearson correlation.
Try
ALAB Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Long entry pick an entry style
Conservative
$357.33
2% below current price (Pullback entry)
Lower risk, wait for pullback
Aggressive
$364.62
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$324.70
MAX LOSS
-9.1%
Volatility-Adjusted Stop Loss
Calculated based on RSI (62.8) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$375.19
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$393.06
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$410.93
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
High-Volatility Risk Disclaimer
ALAB is classified as a high-volatility asset (Daily Vol: 5.36%). Aggressive price swings can lead to rapid capital loss. Liquidity risks may prevent exiting trades at desired prices. This AI-generated analysis is for educational purposes only and is not financial advice. Generated on September 27, 2026.Growth of $10,000
A $10,000 investment in ALAB in March 2024 would be worth about $58,781 today, compared with about $14,820 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ALAB today could grow to about $46,309 by 2036 in the base case, with a bull case near $351,331 and a bear case around $6,104. Projections are statistical simulations, not guarantees.
ALAB Stock Price Prediction: 2030
CleaRank's simulation projects a price near $673 for ALAB by 2030 in the base case, from $365 today (1.8x over 4 years). The downside path ends near $187. These are outcomes of a Monte Carlo simulation run on ALAB's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $224 | $425 | $807 |
| 2028 | $200 | $495 | $1,226 |
| 2029 | $190 | $577 | $1,752 |
| 2030 | $187 | $673 | $2,425 |
| 2031 | $187 | $785 | $3,288 |
| 2032 | $190 | $915 | $4,395 |
| 2033 | $196 | $1,066 | $5,809 |
| 2034 | $203 | $1,243 | $7,612 |
| 2035 | $212 | $1,449 | $9,904 |
| 2036 | $223 | $1,689 | $12,810 |
Method: 10,000 simulated price paths using ALAB's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. ALAB is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
ALAB Insider Trading Analysis
Bought
None
No open-market buys
Sold
$1.2B
85 Transactions
Insiders
12
Active Traders
Avg Transaction
$13.9M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | GAJENDRA SANJAY
President
|
Sell | 400.0K | $116.1M |
| Nov 7, 2024 | GAJENDRA SANJAY
President
|
Sell | 740.0K | $71.5M |
| May 19, 2026 | GAJENDRA SANJAY
President
|
Sell | 280.0K | $69.8M |
| Jul 1, 2026 | ALBA MANUEL
Director
|
Sell | 137.0K | $60.5M |
| Apr 20, 2026 | MOHAN JITENDRA
Chief Executive Officer
|
Sell | 335.9K | $57.9M |
| Sep 1, 2026 | ALBA MANUEL
Director
|
Sell | 183.0K | $51.3M |
| Aug 7, 2025 | GAJENDRA SANJAY
President
|
Sell | 280.0K | $47.6M |
| May 7, 2026 | GAJENDRA SANJAY
President
|
Sell | 230.6K | $45.7M |
| May 30, 2025 | TATE MICHAEL TRUETT
Chief Financial Officer
|
Sell | 500.0K | $45.1M |
| Nov 6, 2024 | MOHAN JITENDRA
Chief Executive Officer
|
Sell | 423.8K | $39.0M |
Page 1 of 1
Frequently Asked Questions
Is Astera Labs, Inc. stock a buy right now?
Astera Labs, Inc. (ALAB) is currently rated a 'Buy' by Wall Street analysts with a median price target of $425.00, suggesting a 16.6% upside from its current price of $364.62. The stock exhibits bullish technical momentum and strong revenue growth, but significant insider selling and a high valuation warrant careful consideration.
What is Astera Labs, Inc.'s price forecast for 2030?
Based on Monte Carlo simulations, Astera Labs, Inc.'s base case price projection for 2030 is $673.14, with a downside scenario at $186.86. These figures represent statistical outcomes and are not guaranteed price targets.
What are the biggest risks facing Astera Labs, Inc.?
The most significant risks include substantial insider selling exceeding $1.2 billion, a premium valuation compared to sector peers, and potential investor reaction to earnings reports despite beats, as seen in the June 2026 quarter's price drop.
How does Astera Labs, Inc. compare to its sector averages?
Astera Labs, Inc. significantly outperforms the technology sector in revenue growth (104.5% vs 24.1%) and has a much lower debt-to-equity ratio (0.03 vs sector median). However, its P/E (180.50 vs 34) and P/S (52.63 vs 7.5) ratios are considerably higher, indicating a premium valuation.
What is the analyst consensus for Astera Labs, Inc. stock?
The current Wall Street consensus for Astera Labs, Inc. is 'Buy', with 26 analysts covering the stock. The median price target is $425.00, and the consensus score is 75 out of 100.
What is Astera Labs, Inc.'s current technical momentum?
Astera Labs, Inc. shows bullish technical momentum, trading above its 50-day and 200-day moving averages ($305.03 and $236.21) with an RSI at 62.8. The stock is positioned favorably on its charts, indicating a positive short-term outlook.
Are insiders buying or selling Astera Labs, Inc. stock?
Insiders of Astera Labs, Inc. are net sellers, with total sales amounting to approximately $1.2 billion and no reported purchases. This heavy selling pressure is a key factor to monitor.